table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Self-administered Drugs Market Size Analysis from 2023 to 2028
1.5.1 Global Self-administered Drugs Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Self-administered Drugs Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Self-administered Drugs Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Self-administered Drugs Industry Impact
Chapter 2 Global Self-administered Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Self-administered Drugs (Volume and Value) by Type
2.1.1 Global Self-administered Drugs Consumption and Market Share by Type (2017-2022)
2.1.2 Global Self-administered Drugs Revenue and Market Share by Type (2017-2022)
2.2 Global Self-administered Drugs (Volume and Value) by Application
2.2.1 Global Self-administered Drugs Consumption and Market Share by Application (2017-2022)
2.2.2 Global Self-administered Drugs Revenue and Market Share by Application (2017-2022)
2.3 Global Self-administered Drugs (Volume and Value) by Regions
2.3.1 Global Self-administered Drugs Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Self-administered Drugs Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Self-administered Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Self-administered Drugs Consumption by Regions (2017-2022)
4.2 North America Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
4.10 South America Self-administered Drugs Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Self-administered Drugs Market Analysis
5.1 North America Self-administered Drugs Consumption and Value Analysis
5.1.1 North America Self-administered Drugs Market Under COVID-19
5.2 North America Self-administered Drugs Consumption Volume by Types
5.3 North America Self-administered Drugs Consumption Structure by Application
5.4 North America Self-administered Drugs Consumption by Top Countries
5.4.1 United States Self-administered Drugs Consumption Volume from 2017 to 2022
5.4.2 Canada Self-administered Drugs Consumption Volume from 2017 to 2022
5.4.3 Mexico Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 6 East Asia Self-administered Drugs Market Analysis
6.1 East Asia Self-administered Drugs Consumption and Value Analysis
6.1.1 East Asia Self-administered Drugs Market Under COVID-19
6.2 East Asia Self-administered Drugs Consumption Volume by Types
6.3 East Asia Self-administered Drugs Consumption Structure by Application
6.4 East Asia Self-administered Drugs Consumption by Top Countries
6.4.1 China Self-administered Drugs Consumption Volume from 2017 to 2022
6.4.2 Japan Self-administered Drugs Consumption Volume from 2017 to 2022
6.4.3 South Korea Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 7 Europe Self-administered Drugs Market Analysis
7.1 Europe Self-administered Drugs Consumption and Value Analysis
7.1.1 Europe Self-administered Drugs Market Under COVID-19
7.2 Europe Self-administered Drugs Consumption Volume by Types
7.3 Europe Self-administered Drugs Consumption Structure by Application
7.4 Europe Self-administered Drugs Consumption by Top Countries
7.4.1 Germany Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.2 UK Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.3 France Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.4 Italy Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.5 Russia Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.6 Spain Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.7 Netherlands Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.8 Switzerland Self-administered Drugs Consumption Volume from 2017 to 2022
7.4.9 Poland Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 8 South Asia Self-administered Drugs Market Analysis
8.1 South Asia Self-administered Drugs Consumption and Value Analysis
8.1.1 South Asia Self-administered Drugs Market Under COVID-19
8.2 South Asia Self-administered Drugs Consumption Volume by Types
8.3 South Asia Self-administered Drugs Consumption Structure by Application
8.4 South Asia Self-administered Drugs Consumption by Top Countries
8.4.1 India Self-administered Drugs Consumption Volume from 2017 to 2022
8.4.2 Pakistan Self-administered Drugs Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Self-administered Drugs Market Analysis
9.1 Southeast Asia Self-administered Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Self-administered Drugs Market Under COVID-19
9.2 Southeast Asia Self-administered Drugs Consumption Volume by Types
9.3 Southeast Asia Self-administered Drugs Consumption Structure by Application
9.4 Southeast Asia Self-administered Drugs Consumption by Top Countries
9.4.1 Indonesia Self-administered Drugs Consumption Volume from 2017 to 2022
9.4.2 Thailand Self-administered Drugs Consumption Volume from 2017 to 2022
9.4.3 Singapore Self-administered Drugs Consumption Volume from 2017 to 2022
9.4.4 Malaysia Self-administered Drugs Consumption Volume from 2017 to 2022
9.4.5 Philippines Self-administered Drugs Consumption Volume from 2017 to 2022
9.4.6 Vietnam Self-administered Drugs Consumption Volume from 2017 to 2022
9.4.7 Myanmar Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 10 Middle East Self-administered Drugs Market Analysis
10.1 Middle East Self-administered Drugs Consumption and Value Analysis
10.1.1 Middle East Self-administered Drugs Market Under COVID-19
10.2 Middle East Self-administered Drugs Consumption Volume by Types
10.3 Middle East Self-administered Drugs Consumption Structure by Application
10.4 Middle East Self-administered Drugs Consumption by Top Countries
10.4.1 Turkey Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.3 Iran Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.5 Israel Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.6 Iraq Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.7 Qatar Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.8 Kuwait Self-administered Drugs Consumption Volume from 2017 to 2022
10.4.9 Oman Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 11 Africa Self-administered Drugs Market Analysis
11.1 Africa Self-administered Drugs Consumption and Value Analysis
11.1.1 Africa Self-administered Drugs Market Under COVID-19
11.2 Africa Self-administered Drugs Consumption Volume by Types
11.3 Africa Self-administered Drugs Consumption Structure by Application
11.4 Africa Self-administered Drugs Consumption by Top Countries
11.4.1 Nigeria Self-administered Drugs Consumption Volume from 2017 to 2022
11.4.2 South Africa Self-administered Drugs Consumption Volume from 2017 to 2022
11.4.3 Egypt Self-administered Drugs Consumption Volume from 2017 to 2022
11.4.4 Algeria Self-administered Drugs Consumption Volume from 2017 to 2022
11.4.5 Morocco Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 12 Oceania Self-administered Drugs Market Analysis
12.1 Oceania Self-administered Drugs Consumption and Value Analysis
12.2 Oceania Self-administered Drugs Consumption Volume by Types
12.3 Oceania Self-administered Drugs Consumption Structure by Application
12.4 Oceania Self-administered Drugs Consumption by Top Countries
12.4.1 Australia Self-administered Drugs Consumption Volume from 2017 to 2022
12.4.2 New Zealand Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 13 South America Self-administered Drugs Market Analysis
13.1 South America Self-administered Drugs Consumption and Value Analysis
13.1.1 South America Self-administered Drugs Market Under COVID-19
13.2 South America Self-administered Drugs Consumption Volume by Types
13.3 South America Self-administered Drugs Consumption Structure by Application
13.4 South America Self-administered Drugs Consumption Volume by Major Countries
13.4.1 Brazil Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.2 Argentina Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.3 Columbia Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.4 Chile Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.5 Venezuela Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.6 Peru Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Self-administered Drugs Consumption Volume from 2017 to 2022
13.4.8 Ecuador Self-administered Drugs Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Self-administered Drugs Business
14.1 Abbott Laboratories
14.1.1 Abbott Laboratories Company Profile
14.1.2 Abbott Laboratories Self-administered Drugs Product Specification
14.1.3 Abbott Laboratories Self-administered Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Bristol-Myers Squibb
14.2.1 Bristol-Myers Squibb Company Profile
14.2.2 Bristol-Myers Squibb Self-administered Drugs Product Specification
14.2.3 Bristol-Myers Squibb Self-administered Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Novartis AG
14.3.1 Novartis AG Company Profile
14.3.2 Novartis AG Self-administered Drugs Product Specification
14.3.3 Novartis AG Self-administered Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Eli Lilly and Company
14.4.1 Eli Lilly and Company Company Profile
14.4.2 Eli Lilly and Company Self-administered Drugs Product Specification
14.4.3 Eli Lilly and Company Self-administered Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Gilead Sciences
14.5.1 Gilead Sciences Company Profile
14.5.2 Gilead Sciences Self-administered Drugs Product Specification
14.5.3 Gilead Sciences Self-administered Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Antares Pharma
14.6.1 Antares Pharma Company Profile
14.6.2 Antares Pharma Self-administered Drugs Product Specification
14.6.3 Antares Pharma Self-administered Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Self-administered Drugs Market Forecast (2023-2028)
15.1 Global Self-administered Drugs Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Self-administered Drugs Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Self-administered Drugs Value and Growth Rate Forecast (2023-2028)
15.2 Global Self-administered Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Self-administered Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Self-administered Drugs Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Self-administered Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Self-administered Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Self-administered Drugs Consumption Forecast by Type (2023-2028)
15.3.2 Global Self-administered Drugs Revenue Forecast by Type (2023-2028)
15.3.3 Global Self-administered Drugs Price Forecast by Type (2023-2028)
15.4 Global Self-administered Drugs Consumption Volume Forecast by Application (2023-2028)
15.5 Self-administered Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
